Roles of the Unsaturated Fatty Acid Docosahexaenoic Acid in the Central Nervous System: Molecular and Cellular Insights
Abstract
:1. General Aspects of Fatty Acids
2. An Overview on DHA Effects in the CNS
2.1. DHA Actions on Neural Cell Survival
2.2. DHA Effects on Neural Morphology
2.3. DHA as Modulator of Synaptic Function
2.4. DHA Effects on CNS Disorders
2.4.1. DHA Effects on Neurodegenerative Diseases
2.4.2. ω-3 PUFAs and the Control of Obesity
2.4.3. DHA Roles in CNS Tumors
3. Concluding Remarks
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Tvrzicka, E.; Kremmyda, L.-S.; Stankova, B.; Zak, A. Fatty Acids as Biocompounds: Their Role in Human Metabolism, Health and Disease—A Review. Part 1: Classification, Dietary Sources and Biological Functions. Biomed. Pap. 2011, 155, 117–130. [Google Scholar] [CrossRef] [PubMed]
- Sinclair, A.J. Docosahexaenoic acid and the brain- what is its role? Asia Pac. J. Clin. Nutr. 2019, 28, 675–688. [Google Scholar] [PubMed]
- Burdge, G.C.; Calder, P.C. Introduction to Fatty Acids and Lipids. World Rev. Nutr. Diet. 2014, 112, 1–16. [Google Scholar] [PubMed]
- Calder, P.C. Docosahexaenoic Acid. Ann. Nutr. Metab. 2016, 69 (Suppl. S1), 8–21. [Google Scholar] [CrossRef]
- Wall, R.; Ross, R.P.; Fitzgerald, G.F.; Stanton, C. Fatty acids from fish: The anti-inflammatory potential of long-chain omega-3 fatty acids. Nutr. Rev. 2010, 68, 280–289. [Google Scholar] [CrossRef]
- Kimura, I.; Ichimura, A.; Ohue-Kitano, R.; Igarashi, M. Free Fatty Acid Receptors in Health and Disease. Physiol. Rev. 2020, 100, 171–210. [Google Scholar] [CrossRef]
- Chevalier, L.; Vachon, A.; Plourde, M. Pharmacokinetics of Supplemental Omega-3 Fatty Acids Esterified in Monoglycerides, Ethyl Esters, or Triglycerides in Adults in a Randomized Crossover Trial. J. Nutr. 2021, 151, 1111–1118. [Google Scholar] [CrossRef]
- Rustan, A.C.; Drevon, C.A. Fatty Acids: Structures and Properties. In eLS; John Wiley & Sons, Ltd.: Hoboken, NJ, USA, 2005. [Google Scholar]
- Moghadasian, M.H.; Shahidi, F. Fatty Acids. In International Encyclopedia of Public Health, 2nd ed.; Quah, S.R., Ed.; Academic Press: Oxford, UK, 2017; pp. 114–122. [Google Scholar]
- DeFilippis, A.P.; Sperling, L.S. Understanding omega-3′s. Am. Heart J. 2006, 151, 564–570. [Google Scholar] [CrossRef]
- Harauma, A.; Yasuda, H.; Hatanaka, E.; Nakamura, M.T.; Salem, N., Jr.; Moriguchi, T. The essentiality of arachidonic acid in addition to docosahexaenoic acid for brain growth and function. Prostaglandins Leukot. Essent. Fat. Acids 2017, 116, 9–18. [Google Scholar] [CrossRef]
- Bazinet, R.P.; Layé, S. Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat. Rev. Neurosci. 2014, 15, 771–785. [Google Scholar] [CrossRef]
- Liu, J.J.; Green, P.; John Mann, J.; Rapoport, S.I.; Sublette, M.E. Pathways of polyunsaturated fatty acid utilization: Implications for brain function in neuropsychiatric health and disease. Brain Res. 2015, 1597, 220–246. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Montecillo-Aguado, M.; Tirado-Rodriguez, B.; Tong, Z.; Vega, O.M.; Morales-Martínez, M.; Abkenari, S.; Pedraza-Chaverri, J.; Huerta-Yepez, S. Importance of the Role of ω-3 and ω-6 Polyunsaturated Fatty Acids in the Progression of Brain Cancer. Brain Sci. 2020, 10, 381. [Google Scholar] [CrossRef] [PubMed]
- Echeverría, F.; Valenzuela, R.; Catalina Hernandez-Rodas, M.; Valenzuela, A. Docosahexaenoic acid (DHA), a fundamental fatty acid for the brain: New dietary sources. Prostaglandins Leukot. Essent. Fat. Acids 2017, 124, 1–10. [Google Scholar] [CrossRef] [PubMed]
- Bazan, N.G.; Musto, A.E.; Knott, E.J. Endogenous Signaling by Omega-3 Docosahexaenoic Acid-derived Mediators Sustains Homeostatic Synaptic and Circuitry Integrity. Mol. Neurobiol. 2011, 44, 216–222. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ulven, S.M.; Kirkhus, B.; Lamglait, A.; Basu, S.; Elind, E.; Haider, T.; Berge, K.; Vik, H.; Pedersen, J.I. Metabolic Effects of Krill Oil are Essentially Similar to Those of Fish Oil but at Lower Dose of EPA and DHA, in Healthy Volunteers. Lipids 2011, 46, 37–46. [Google Scholar] [CrossRef] [Green Version]
- Lacombe, R.J.S.; Chouinard-Watkins, R.; Bazinet, R.P. Brain docosahexaenoic acid uptake and metabolism. Mol. Asp. Med. 2018, 64, 109–134. [Google Scholar] [CrossRef]
- Plourde, M.; Cunnane, S.C. Extremely limited synthesis of long chain polyunsaturates in adults: Implications for their dietary essentiality and use as supplements. Appl. Physiol. Nutr. Metab. 2007, 32, 619–634. [Google Scholar] [CrossRef] [Green Version]
- Rapoport, S.I.; Rao, J.S.; Igarashi, M. Brain metabolism of nutritionally essential polyunsaturated fatty acids depends on both the diet and the liver. Prostaglandins Leukot. Essent. Fat. Acids 2007, 77, 251–261. [Google Scholar] [CrossRef] [Green Version]
- Domenichiello, A.F.; Kitson, A.P.; Bazinet, R.P. Is docosahexaenoic acid synthesis from α-linolenic acid sufficient to supply the adult brain? Prog. Lipid Res. 2015, 59, 54–66. [Google Scholar] [CrossRef] [Green Version]
- Devarshi, P.P.; Grant, R.W.; Ikonte, C.J.; Hazels Mitmesser, S. Maternal Omega-3 Nutrition, Placental Transfer and Fetal Brain Development in Gestational Diabetes and Preeclampsia. Nutrients 2019, 11, 1107. [Google Scholar] [CrossRef] [Green Version]
- Diau, G.-Y.; Hsieh, A.T.; Sarkadi-Nagy, E.A.; Wijendran, V.; Nathanielsz, P.W.; Brenna, J.T. The influence of long chain polyunsaturate supplementation on docosahexaenoic acid and arachidonic acid in baboon neonate central nervous system. BMC Med. 2005, 3, 11. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hsieh, A.T.; Brenna, J.T. Dietary docosahexaenoic acid but not arachidonic acid influences central nervous system fatty acid status in baboon neonates. Prostaglandins Leukot. Essent. Fat. Acids 2009, 81, 105–110. [Google Scholar] [CrossRef] [PubMed]
- Martínez, M.; Mougan, I. Fatty Acid Composition of Human Brain Phospholipids During Normal Development. J. Neurochem. 2002, 71, 2528–2533. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Horrocks, L.A.; Farooqui, A.A. Docosahexaenoic acid in the diet: Its importance in maintenance and restoration of neural membrane function. Prostaglandins Leukot. Essent. Fat. Acids 2004, 70, 361–372. [Google Scholar] [CrossRef] [PubMed]
- Shina, R.; Crain, R.C.; Rosenberg, P.; Condrea, E. The asymmetric distribution of phosphatidylcholine in rat brain synaptic plasma membranes. Neurochem. Int. 1993, 22, 189–195. [Google Scholar] [CrossRef]
- Ikemoto, A.; Ohishi, M.; Hata, N.; Misawa, Y.; Fujii, Y.; Okuyama, H. Effect of n−3 fatty acid deficiency on fatty acid composition and metabolism of aminophospholipids in rat brain synaptosomes. Lipids 2000, 35, 1107–1115. [Google Scholar] [CrossRef] [PubMed]
- Glomset, J.A. Role of Docosahexaenoic Acid in Neuronal Plasma Membranes. Sci. STKE 2006, 2006, pe6. [Google Scholar] [CrossRef] [PubMed]
- Falomir-Lockhart, L.J.; Cavazzutti, G.F.; Giménez, E.; Toscani, A.M. Fatty Acid Signaling Mechanisms in Neural Cells: Fatty Acid Receptors. Front. Cell. Neurosci. 2019, 13, 162. [Google Scholar] [CrossRef]
- Cao, D.; Xue, R.; Xu, J.; Liu, Z. Effects of docosahexaenoic acid on the survival and neurite outgrowth of rat cortical neurons in primary cultures. J. Nutr. Biochem. 2005, 16, 538–546. [Google Scholar] [CrossRef]
- Dyall, S.C. Long-chain omega-3 fatty acids and the brain: A review of the independent and shared effects of EPA, DPA and DHA. Front. Aging Neurosci. 2015, 7, 52. [Google Scholar] [CrossRef] [Green Version]
- Tang, M.; Zhang, M.; Wang, L.; Li, H.; Cai, H.; Dang, R.; Jiang, P.; Liu, Y.; Xue, Y.; Wu, Y. Maternal dietary of n-3 polyunsaturated fatty acids affects the neurogenesis and neurochemical in female rat at weaning. Prostaglandins Leukot. Essent. Fat. Acids 2018, 128, 11–20. [Google Scholar] [CrossRef] [PubMed]
- Calon, F.; Lim, G.P.; Yang, F.; Morihara, T.; Teter, B.; Ubeda, O.; Rostaing, P.; Triller, A.; Salem, N.; Ashe, K.H.; et al. Docosahexaenoic Acid Protects from Dendritic Pathology in an Alzheimer’s Disease Mouse Model. Neuron 2004, 43, 633–645. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Dyall, S.C.; Michael-Titus, A.T. Neurological Benefits of Omega-3 Fatty Acids. NeuroMol. Med. 2008, 10, 219–235. [Google Scholar] [CrossRef] [PubMed]
- Nakamoto, K.; Nishinaka, T.; Matsumoto, K.; Kasuya, F.; Mankura, M.; Koyama, Y.; Tokuyama, S. Involvement of the long-chain fatty acid receptor GPR40 as a novel pain regulatory system. Brain Res. 2012, 1432, 74–83. [Google Scholar] [CrossRef] [PubMed]
- Ramsden, C.E.; Domenichiello, A.F.; Yuan, Z.-X.; Sapio, M.R.; Keyes, G.S.; Mishra, S.K.; Gross, J.R.; Majchrzak-Hong, S.; Zamora, D.; Horowitz, M.S.; et al. A systems approach for discovering linoleic acid derivatives that potentially mediate pain and itch. Sci. Signal. 2017, 10, eaal5241. [Google Scholar] [CrossRef] [Green Version]
- Kunder, S.K.; Bairy, L.K.; Arivazhahan, A. Effect of Sodium Valproate and Docosahexaenoic Acid on Pain in Rats. J. Clin. Diagn. Res. 2017, 11, ff05–ff08. [Google Scholar] [CrossRef]
- Chang, C.-K.; Chen, P.-K.; Chen, C.-C.; Chang, S.-H.; Chen, C.-H.; Chen, D.-Y. Increased Levels of Omega-3 Fatty Acids and DHA Are Linked to Pain Reduction in Rheumatoid Arthritis Patients Treated with Janus Kinase Inhibitors. Nutrients 2021, 13, 3050. [Google Scholar] [CrossRef]
- Ramsden, C.E.; Zamora, D.; Faurot, K.R.; Macintosh, B.; Horowitz, M.; Keyes, G.S.; Yuan, Z.-X.; Miller, V.; Lynch, C.; Honvoh, G.; et al. Dietary alteration of n-3 and n-6 fatty acids for headache reduction in adults with migraine: Randomized controlled trial. BMJ 2021, 374, n1448. [Google Scholar] [CrossRef]
- Agbaga, M.-P.; Merriman, D.K.; Brush, R.S.; Lydic, T.A.; Conley, S.M.; Naash, M.I.; Jackson, S.; Woods, A.S.; Reid, G.E.; Busik, J.V.; et al. Differential composition of DHA and very-long-chain PUFAs in rod and cone photoreceptors. J. Lipid Res. 2018, 59, 1586–1596. [Google Scholar] [CrossRef] [Green Version]
- Shindou, H.; Koso, H.; Sasaki, J.; Nakanishi, H.; Sagara, H.; Nakagawa, K.M.; Takahashi, Y.; Hishikawa, D.; Iizuka-Hishikawa, Y.; Tokumasu, F.; et al. Docosahexaenoic acid preserves visual function by maintaining correct disc morphology in retinal photoreceptor cells. J. Biol. Chem. 2017, 292, 12054–12064. [Google Scholar] [CrossRef] [Green Version]
- Rodríguez González-Herrero, M.E.; Ruiz, M.; López Román, F.J.; Marín Sánchez, J.M.; Domingo, J.C. Supplementation with a highly concentrated docosahexaenoic acid plus xanthophyll carotenoid multivitamin in nonproliferative diabetic retinopathy: Prospective controlled study of macular function by fundus microperimetry. Clin. Ophthalmol. 2018, 12, 1011–1020. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wheeler, T.G.; Benolken, R.M.; Anderson, R.E. Visual membranes: Specificity of fatty acid precursors for the electrical response to illumination. Science 1975, 188, 1312–1314. [Google Scholar] [CrossRef] [PubMed]
- Bourre, J.M.; Francois, M.; Youyou, A.; Dumont, O.; Piciotti, M.; Pascal, G.; Durand, G. The effects of dietary alpha-linolenic acid on the composition of nerve membranes, enzymatic activity, amplitude of electrophysiological parameters, resistance to poisons and performance of learning tasks in rats. J. Nutr. 1989, 119, 1880–1892. [Google Scholar] [CrossRef] [PubMed]
- Bush, R.A.; Malnoë, A.; Remé, C.E.; Williams, T.P. Dietary deficiency of N-3 fatty acids alters rhodopsin content and function in the rat retina. Investig. Ophthalmol. Vis. Sci. 1994, 35, 91–100. [Google Scholar]
- Karger, A.B.; Guan, W.; Nomura, S.O.; Weir, N.L.; Klein, B.E.K.; Burke, G.L.; Johnson, W.C.; Tsai, M.Y. Association of plasma ω-3 fatty acids with early age-related macular degeneration in the Multi-Ethnic Study of Atherosclerosis (MESA). Retina 2022. [Google Scholar] [CrossRef]
- Ruiz-Pastor, M.J.; Kutsyr, O.; Lax, P.; Cuenca, N. Decrease in DHA and other fatty acids correlates with photoreceptor degeneration in retinitis pigmentosa. Exp. Eye Res. 2021, 209, 108667. [Google Scholar] [CrossRef]
- Sandre, P.C.; da Silva Chagas, L.; de Velasco, P.C.; Galvani, R.G.; Dias Fraga, K.Y.; Tavares do Carmo, M.D.G.; Vianna, P.H.O.; Bonomo, A.C.; Serfaty, C.A. Chronic nutritional restriction of omega-3 fatty acids induces a pro-inflammatory profile during the development of the rat visual system. Brain Res. Bull. 2021, 174, 366–378. [Google Scholar] [CrossRef]
- Kalogerou, M.; Ioannou, S.; Kolovos, P.; Prokopiou, E.; Potamiti, L.; Kyriacou, K.; Panagiotidis, M.; Ioannou, M.; Fella, E.; Worth, E.P.; et al. Omega-3 fatty acids promote neuroprotection, decreased apoptosis and reduced glial cell activation in the retina of a mouse model of OPA1-related autosomal dominant optic atrophy. Exp. Eye Res. 2022, 215, 108901. [Google Scholar] [CrossRef]
- Deng, Q.; Wang, Y.; Wang, C.; Ji, B.; Cong, R.; Zhao, L.; Chen, P.; Zang, X.; Lu, F.; Han, F.; et al. Dietary supplementation with omega-3 polyunsaturated fatty acid-rich oils protects against visible-light-induced retinal damage in vivo. Food Funct. 2018, 9, 2469–2479. [Google Scholar] [CrossRef]
- Sugasini, D.; Yalagala, P.C.R.; Subbaiah, P.V. Efficient Enrichment of Retinal DHA with Dietary Lysophosphatidylcholine-DHA: Potential Application for Retinopathies. Nutrients 2020, 12, 3114. [Google Scholar] [CrossRef]
- Greiner, R.S.; Moriguchi, T.; Slotnick, B.M.; Hutton, A.; Salem, N. Olfactory discrimination deficits in n-3 fatty acid-deficient rats. Physiol. Behav. 2001, 72, 379–385. [Google Scholar] [CrossRef]
- Hichami, A.; Datiche, F.; Ullah, S.; Liénard, F.; Chardigny, J.M.; Cattarelli, M.; Khan, N.A. Olfactory discrimination ability and brain expression of c-fos, Gir and Glut1 mRNA are altered in n-3 fatty acid-depleted rats. Behav. Brain Res. 2007, 184, 1–10. [Google Scholar] [CrossRef] [PubMed]
- Bourre, J.M.; Durand, G.; Erre, J.P.; Aran, J.M. Changes in auditory brainstem responses in alpha-linolenic acid deficiency as a function of age in rats. Audiology 1999, 38, 13–18. [Google Scholar] [CrossRef] [PubMed]
- Hafandi, A.; Begg, D.P.; Premaratna, S.D.; Sinclair, A.J.; Jois, M.; Weisinger, R.S. Dietary repletion with ω3 fatty acid or with COX inhibition reverses cognitive effects in F3 ω3 fatty-acid-deficient mice. Comp. Med. 2014, 64, 106–109. [Google Scholar] [PubMed]
- Rao, J.S.; Ertley, R.N.; DeMar, J.C., Jr.; Rapoport, S.I.; Bazinet, R.P.; Lee, H.J. Dietary n-3 PUFA deprivation alters expression of enzymes of the arachidonic and docosahexaenoic acid cascades in rat frontal cortex. Mol. Psychiatry 2007, 12, 151–157. [Google Scholar] [CrossRef]
- Begg, D.P.; Puskás, L.G.; Kitajka, K.; Ménesi, D.; Allen, A.M.; Li, D.; Mathai, M.L.; Shi, J.R.; Sinclair, A.J.; Weisinger, R.S. Hypothalamic gene expression in ω-3 PUFA-deficient male rats before, and following, development of hypertension. Hypertens. Res. 2012, 35, 381–387. [Google Scholar] [CrossRef] [Green Version]
- Pifferi, F.; Jouin, M.; Alessandri, J.M.; Roux, F.; Perrière, N.; Langelier, B.; Lavialle, M.; Cunnane, S.; Guesnet, P. n-3 long-chain fatty acids and regulation of glucose transport in two models of rat brain endothelial cells. Neurochem. Int. 2010, 56, 703–710. [Google Scholar] [CrossRef]
- Pifferi, F.; Dorieux, O.; Castellano, C.A.; Croteau, E.; Masson, M.; Guillermier, M.; Van Camp, N.; Guesnet, P.; Alessandri, J.M.; Cunnane, S.; et al. Long-chain n-3 PUFAs from fish oil enhance resting state brain glucose utilization and reduce anxiety in an adult nonhuman primate, the grey mouse lemur. J. Lipid Res. 2015, 56, 1511–1518. [Google Scholar] [CrossRef] [Green Version]
- Bowen, R.A.; Clandinin, M.T. Dietary low linolenic acid compared with docosahexaenoic acid alter synaptic plasma membrane phospholipid fatty acid composition and sodium-potassium ATPase kinetics in developing rats. J. Neurochem. 2002, 83, 764–774. [Google Scholar] [CrossRef] [Green Version]
- Pifferi, F.; Roux, F.; Langelier, B.; Alessandri, J.M.; Vancassel, S.; Jouin, M.; Lavialle, M.; Guesnet, P. (n-3) polyunsaturated fatty acid deficiency reduces the expression of both isoforms of the brain glucose transporter GLUT1 in rats. J. Nutr. 2005, 135, 2241–2246. [Google Scholar] [CrossRef] [Green Version]
- Serhan, C.N. Pro-resolving lipid mediators are leads for resolution physiology. Nature 2014, 510, 92–101. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kim, H.Y.; Spector, A.A.; Xiong, Z.M. A synaptogenic amide N-docosahexaenoylethanolamide promotes hippocampal development. Prostaglandins Other Lipid Mediat. 2011, 96, 114–120. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lee, J.W.; Huang, B.X.; Kwon, H.; Rashid, M.A.; Kharebava, G.; Desai, A.; Patnaik, S.; Marugan, J.; Kim, H.Y. Orphan GPR110 (ADGRF1) targeted by N-docosahexaenoylethanolamine in development of neurons and cognitive function. Nat. Commun. 2016, 7, 13123. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Antollini, S.S.; Barrantes, F.J. Fatty Acid Regulation of Voltage- and Ligand-Gated Ion Channel Function. Front. Physiol. 2016, 7, 573. [Google Scholar] [CrossRef] [PubMed]
- Grundmann, M.; Bender, E.; Schamberger, J.; Eitner, F. Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators. Int. J. Mol. Sci. 2021, 22, 1763. [Google Scholar] [CrossRef] [PubMed]
- Briscoe, C.P.; Tadayyon, M.; Andrews, J.L.; Benson, W.G.; Chambers, J.K.; Eilert, M.M.; Ellis, C.; Elshourbagy, N.A.; Goetz, A.S.; Minnick, D.T.; et al. The Orphan G Protein-coupled Receptor GPR40 Is Activated by Medium and Long Chain Fatty Acids. J. Biol. Chem. 2003, 278, 11303–11311. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Itoh, Y.; Kawamata, Y.; Harada, M.; Kobayashi, M.; Fujii, R.; Fukusumi, S.; Ogi, K.; Hosoya, M.; Tanaka, Y.; Uejima, H.; et al. Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40. Nature 2003, 422, 173–176. [Google Scholar] [CrossRef]
- Offermanns, S. Free Fatty Acid (FFA) and Hydroxy Carboxylic Acid (HCA) Receptors. Annu. Rev. Pharmacol. Toxicol. 2014, 54, 407–434. [Google Scholar] [CrossRef]
- Nakamoto, K.; Nishinaka, T.; Sato, N.; Aizawa, F.; Yamashita, T.; Mankura, M.; Koyama, Y.; Kasuya, F.; Tokuyama, S. The activation of supraspinal GPR40/FFA1 receptor signalling regulates the descending pain control system. Br. J. Pharmacol. 2015, 172, 1250–1262. [Google Scholar] [CrossRef] [Green Version]
- Nakamoto, K.; Aizawa, F.; Miyagi, K.; Yamashita, T.; Mankura, M.; Koyama, Y.; Kasuya, F.; Hirasawa, A.; Kurihara, T.; Miyata, A.; et al. Dysfunctional GPR40/FFAR1 signaling exacerbates pain behavior in mice. PLoS ONE 2017, 12, e0180610. [Google Scholar] [CrossRef] [Green Version]
- Uauy, R.; Dangour, A.D. Nutrition in brain development and aging: Role of essential fatty acids. Nutr. Rev. 2006, 64 Pt 2, S24–S33, discussion S72–S91. [Google Scholar] [CrossRef] [PubMed]
- Zhao, W.-N.; Hylton, N.K.; Wang, J.; Chindavong, P.S.; Alural, B.; Kurtser, I.; Subramanian, A.; Mazitschek, R.; Perlis, R.H.; Haggarty, S.J. Activation of WNT and CREB signaling pathways in human neuronal cells in response to the Omega-3 fatty acid docosahexaenoic acid (DHA). Mol. Cell. Neurosci. 2019, 99, 103386. [Google Scholar] [CrossRef] [PubMed]
- Kawakita, E.; Hashimoto, M.; Shido, O. Docosahexaenoic acid promotes neurogenesis in vitro and in vivo. Neuroscience 2006, 139, 991–997. [Google Scholar] [CrossRef] [PubMed]
- Montero, M.L.; Liu, J.W.; Orozco, J.; Casiano, C.A.; De Leon, M. Docosahexaenoic acid protection against palmitic acid-induced lipotoxicity in NGF-differentiated PC12 cells involves enhancement of autophagy and inhibition of apoptosis and necroptosis. J. Neurochem. 2020, 155, 559–576. [Google Scholar] [CrossRef]
- Clementi, M.; Lazzarino, G.; Sampaolese, B.; Brancato, A.; Tringali, G. DHA protects PC12 cells against oxidative stress and apoptotic signals through the activation of the NFE2L2/HO-1 axis. Int. J. Mol. Med. 2019, 43, 2523–2531. [Google Scholar] [CrossRef] [PubMed]
- Akbar, M.; Calderon, F.; Wen, Z.; Kim, H.Y. Docosahexaenoic acid: A positive modulator of Akt signaling in neuronal survival. Proc. Natl. Acad. Sci. USA 2005, 102, 10858–10863. [Google Scholar] [CrossRef] [Green Version]
- Descorbeth, M.; Figueroa, K.; Serrano-Illán, M.; De León, M. Protective effect of docosahexaenoic acid on lipotoxicity-mediated cell death in Schwann cells: Implication of PI3K/AKT and mTORC2 pathways. Brain Behav. 2018, 8, e01123. [Google Scholar] [CrossRef] [Green Version]
- Tatsumi, Y.; Kato, A.; Sango, K.; Himeno, T.; Kondo, M.; Kato, Y.; Kamiya, H.; Nakamura, J.; Kato, K. Omega-3 polyunsaturated fatty acids exert anti-oxidant effects through the nuclear factor (erythroid-derived 2)-related factor 2 pathway in immortalized mouse Schwann cells. J. Diabetes Investig. 2019, 10, 602–612. [Google Scholar] [CrossRef]
- Srikanth, M.; Chandrasaharan, K.; Zhao, X.; Chayaburakul, K.; Ong, W.-Y.; Herr, D.R. Metabolism of Docosahexaenoic Acid (DHA) Induces Pyroptosis in BV-2 Microglial Cells. NeuroMol. Med. 2018, 20, 504–514. [Google Scholar] [CrossRef]
- Herr, D.R.; Yam, T.Y.A.; Tan, W.S.D.; Koh, S.S.; Wong, W.S.F.; Ong, W.-Y.; Chayaburakul, K. Ultrastructural Characteristics of DHA-Induced Pyroptosis. NeuroMol. Med. 2020, 22, 293–303. [Google Scholar] [CrossRef] [Green Version]
- Yang, B.; Li, R.; Michael Greenlief, C.; Fritsche, K.L.; Gu, Z.; Cui, J.; Lee, J.C.; Beversdorf, D.Q.; Sun, G.Y. Unveiling anti-oxidative and anti-inflammatory effects of docosahexaenoic acid and its lipid peroxidation product on lipopolysaccharide-stimulated BV-2 microglial cells. J. Neuroinflamm. 2018, 15, 1–16. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Das, M.; Das, S. Docosahexaenoic Acid (DHA) Induced Morphological Differentiation of Astrocytes Is Associated with Transcriptional Upregulation and Endocytosis of β2-AR. Mol. Neurobiol. 2019, 56, 2685–2702. [Google Scholar] [CrossRef] [PubMed]
- Bewicz-Binkowska, D.; Zgórzyńska, E.; Dziedzic, B.; Walczewska, A. Docosahexaenoic Acid (DHA) Inhibits FADS2 Expression in Astrocytes but Increases Survival of Neurons Co-cultured with DHA-enriched Astrocytes. Int. J. Mol. Cell. Med. 2019, 8, 232–239. [Google Scholar] [PubMed]
- Kasthuri, N.; Hayworth, K.J.; Berger, D.R.; Schalek, R.L.; Conchello, J.A.; Knowles-Barley, S.; Lee, D.; Vázquez-Reina, A.; Kaynig, V.; Jones, T.R.; et al. Saturated Reconstruction of a Volume of Neocortex. Cell 2015, 162, 648–661. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gouwens, N.W.; Sorensen, S.A.; Berg, J.; Lee, C.; Jarsky, T.; Ting, J.; Sunkin, S.M.; Feng, D.; Anastassiou, C.A.; Barkan, E.; et al. Classification of electrophysiological and morphological neuron types in the mouse visual cortex. Nat. Neurosci. 2019, 22, 1182–1195. [Google Scholar] [CrossRef] [PubMed]
- Friedman, R. Measurements of neuronal morphological variation across the rat neocortex. Neurosci. Lett. 2020, 734, 135077. [Google Scholar] [CrossRef]
- Allen Brain Atlas—Mouse Brain [Brain Atlas]. Available online: https://atlas.brain-map.org/ (accessed on 22 February 2022).
- Zeng, H.; Sanes, J.R. Neuronal cell-type classification: Challenges, opportunities and the path forward. Nat. Rev. Neurosci. 2017, 18, 530–546. [Google Scholar] [CrossRef]
- Ascoli, G.A. Mobilizing the base of neuroscience data: The case of neuronal morphologies. Nat. Rev. Neurosci. 2006, 7, 318–324. [Google Scholar] [CrossRef]
- Scorcioni, R.; Polavaram, S.; Ascoli, G.A. L-Measure: A web-accessible tool for the analysis, comparison and search of digital reconstructions of neuronal morphologies. Nat. Protoc. 2008, 3, 866–876. [Google Scholar] [CrossRef]
- Dagai, L.; Peri-Naor, R.; Birk, R.Z. Docosahexaenoic Acid Significantly Stimulates Immediate Early Response Genes and Neurite Outgrowth. Neurochem. Res. 2009, 34, 867–875. [Google Scholar] [CrossRef]
- Calderon, F.; Kim, H.-Y. Docosahexaenoic acid promotes neurite growth in hippocampal neurons. J. Neurochem. 2004, 90, 979–988. [Google Scholar] [CrossRef] [PubMed]
- Cao, D.; Kevala, K.; Kim, J.; Moon, H.-S.; Jun, S.B.; Lovinger, D.; Kim, H.-Y. Docosahexaenoic acid promotes hippocampal neuronal development and synaptic function. J. Neurochem. 2009, 111, 510–521. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Carbone, B.E.; Abouleish, M.; Watters, K.E.; Vogel, S.; Ribic, A.; Schroeder, O.H.-U.; Bader, B.M.; Biederer, T. Synaptic Connectivity and Cortical Maturation Are Promoted by the ω-3 Fatty Acid Docosahexaenoic Acid. Cereb. Cortex 2019, 30, 226–240. [Google Scholar] [CrossRef] [PubMed]
- Mita, T.; Mayanagi, T.; Ichijo, H.; Fukumoto, K.; Otsuka, K.; Sakai, A.; Sobue, K. Docosahexaenoic Acid Promotes Axon Outgrowth by Translational Regulation of Tau and Collapsin Response Mediator Protein 2 Expression. J. Biol. Chem. 2016, 291, 4955–4965. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Heyman, R.A.; Mangelsdorf, D.J.; Dyck, J.A.; Stein, R.B.; Eichele, G.; Evans, R.M.; Thaller, C. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 1992, 68, 397–406. [Google Scholar] [CrossRef]
- Maden, M. Retinoid signalling in the development of the central nervous system. Nat. Rev. Neurosci. 2002, 3, 843–853. [Google Scholar] [CrossRef] [PubMed]
- De Urquiza, A.M.; Liu, S.; Sjöberg, M.; Zetterström, R.H.; Griffiths, W.; Sjövall, J.; Perlmann, T. Docosahexaenoic Acid, a Ligand for the Retinoid X Receptor in Mouse Brain. Science 2000, 290, 2140–2144. [Google Scholar] [CrossRef]
- Calderon, F.; Kim, H.-Y. Role of RXR in neurite outgrowth induced by docosahexaenoic acid. Prostaglandins Leukot. Essent. Fat. Acids 2007, 77, 227–232. [Google Scholar] [CrossRef] [Green Version]
- Huang, E.J.; Reichardt, L.F. Neurotrophins: Roles in Neuronal Development and Function. Annu. Rev. Neurosci. 2001, 24, 677–736. [Google Scholar] [CrossRef] [Green Version]
- Park, H.; Poo, M.-M. Neurotrophin regulation of neural circuit development and function. Nat. Rev. Neurosci. 2013, 14, 7–23. [Google Scholar] [CrossRef]
- Bhatia, H.S.; Agrawal, R.; Sharma, S.; Huo, Y.-X.; Ying, Z.; Gomez-Pinilla, F. Omega-3 Fatty Acid Deficiency during Brain Maturation Reduces Neuronal and Behavioral Plasticity in Adulthood. PLoS ONE 2011, 6, e28451. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wu, A.; Ying, Z.; Gomez-Pinilla, F. Docosahexaenoic acid dietary supplementation enhances the effects of exercise on synaptic plasticity and cognition. Neuroscience 2008, 155, 751–759. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ma, D.; Zhang, M.; Larsen, C.P.; Xu, F.; Hua, W.; Yamashima, T.; Mao, Y.; Zhou, L. DHA promotes the neuronal differentiation of rat neural stem cells transfected with GPR40 gene. Brain Res. 2010, 1330, 1–8. [Google Scholar] [CrossRef] [PubMed]
- Innis, S.M. Dietary omega 3 fatty acids and the developing brain. Brain Res. 2008, 1237, 35–43. [Google Scholar] [CrossRef]
- Dotti, C.G.; Esteban, J.A.; Ledesma, M.D. Lipid dynamics at dendritic spines. Front. Neuroanat. 2014, 8, 76. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tulodziecka, K.; Diaz-Rohrer, B.B.; Farley, M.M.; Chan, R.B.; Di Paolo, G.; Levental, K.R.; Waxham, M.N.; Levental, I. Remodeling of the postsynaptic plasma membrane during neural development. Mol. Biol. Cell 2016, 27, 3480–3489. [Google Scholar] [CrossRef]
- Sakamoto, T.; Cansev, M.; Wurtman, R.J. Oral supplementation with docosahexaenoic acid and uridine-5′-monophosphate increases dendritic spine density in adult gerbil hippocampus. Brain Res. 2007, 1182, 50–59. [Google Scholar] [CrossRef] [Green Version]
- Sidhu, V.K.; Huang, B.X.; Kim, H.-Y. Effects of Docosahexaenoic Acid on Mouse Brain Synaptic Plasma Membrane Proteome Analyzed by Mass Spectrometry and 16O/18O Labeling. J. Proteome Res. 2011, 10, 5472–5480. [Google Scholar] [CrossRef] [Green Version]
- Connor, S.; Tenorio, G.; Clandinin, M.T.; Sauvé, Y. DHA supplementation enhances high-frequency, stimulation-induced synaptic transmission in mouse hippocampus. Appl. Physiol. Nutr. Metab. 2012, 37, 880–887. [Google Scholar] [CrossRef]
- Fujita, S.; Ikegaya, Y.; Nishikawa, M.; Nishiyama, N.; Matsuki, N. Docosahexaenoic acid improves long-term potentiation attenuated by phospholipase A2 inhibitor in rat hippocampal slices. Br. J. Pharmacol. 2001, 132, 1417–1422. [Google Scholar] [CrossRef] [Green Version]
- Mazzocchi-Jones, D. Impaired corticostriatal LTP and depotentiation following iPLA2 inhibition is restored following acute application of DHA. Brain Res. Bull. 2015, 111, 69–75. [Google Scholar] [CrossRef] [PubMed]
- Pérez, M.Á.; Peñaloza-Sancho, V.; Ahumada, J.; Fuenzalida, M.; Dagnino-Subiabre, A. n-3 Polyunsaturated fatty acid supplementation restored impaired memory and GABAergic synaptic efficacy in the hippocampus of stressed rats. Nutr. Neurosci. 2018, 21, 556–569. [Google Scholar] [CrossRef] [PubMed]
- Nabekura, J.; Noguchi, K.; Witt, M.-R.; Nielsen, M.; Akaike, N. Functional Modulation of Human Recombinant γ-Aminobutyric Acid Type A Receptor by Docosahexaenoic Acid. J. Biol. Chem. 1998, 273, 11056–11061. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nievas, G.A.F.; Barrantes, F.J.; Antollini, S.S. Modulation of Nicotinic Acetylcholine Receptor Conformational State by Free Fatty Acids and Steroids. J. Biol. Chem. 2008, 283, 21478–21486. [Google Scholar] [CrossRef] [Green Version]
- Cordero-Morales, J.F.; Vásquez, V. How lipids contribute to ion channel function, a fat perspective on direct and indirect interactions. Curr. Opin. Struct. Biol. 2018, 51, 92–98. [Google Scholar] [CrossRef]
- Dinicolantonio, J.J.; O’Keefe, J.H. The Importance of Marine Omega-3s for Brain Development and the Prevention and Treatment of Behavior, Mood, and Other Brain Disorders. Nutrients 2020, 12, 2333. [Google Scholar] [CrossRef]
- Guu, T.W.; Mischoulon, D.; Sarris, J.; Hibbeln, J.; McNamara, R.K.; Hamazaki, K.; Freeman, M.P.; Maes, M.; Matsuoka, Y.J.; Belmaker, R.H.; et al. International Society for Nutritional Psychiatry Research Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive Disorder. Psychother. Psychosom. 2019, 88, 263–273. [Google Scholar] [CrossRef]
- San Mauro Martin, I.; Sanz Rojo, S.; González Cosano, L.; Conty de la Campa, R.; Garicano Vilar, E.; Blumenfeld Olivares, J.A. Impulsiveness in children with attention-deficit/hyperactivity disorder after an 8-week intervention with the Mediterranean diet and/or omega-3 fatty acids: A randomised clinical trial. Neurologia (Engl. Ed.) 2019, 26, S0213–4853(19)30132-X. [Google Scholar] [CrossRef]
- Kidd, P.M. Omega-3 DHA and EPA for cognition, behavior, and mood: Clinical findings and structural-functional synergies with cell membrane phospholipids. Altern. Med. Rev. 2007, 12, 207–227. [Google Scholar]
- Vancassel, S.; Durand, G.; Barthélémy, C.; Lejeune, B.; Martineau, J.; Guilloteau, D.; Andrès, C.; Chalon, S. Plasma fatty acid levels in autistic children. Prostaglandins Leukot. Essent. Fat. Acids 2001, 65, 1–7. [Google Scholar] [CrossRef]
- Zanarini, M.C.; Frankenburg, F.R. omega-3 Fatty acid treatment of women with borderline personality disorder: A double-blind, placebo-controlled pilot study. Am. J. Psychiatry 2003, 160, 167–169. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Díaz, M.; Mesa-Herrera, F.; Marín, R. DHA and Its Elaborated Modulation of Antioxidant Defenses of the Brain: Implications in Aging and AD Neurodegeneration. Antioxidants 2021, 10, 907. [Google Scholar] [CrossRef] [PubMed]
- Insua, M.F.; Garelli, A.S.; Rotstein, N.P.; German, O.L.; Arias, A.S.; Politi, L.E. Cell Cycle Regulation in Retinal Progenitors by Glia-Derived Neurotrophic Factor and Docosahexaenoic Acid. Investig. Opthalmol. Vis. Sci. 2003, 44, 2235. [Google Scholar] [CrossRef] [PubMed]
- Sun, G.Y.; Simonyi, A.; Fritsche, K.L.; Chuang, D.Y.; Hannink, M.; Gu, Z.; Greenlief, C.M.; Yao, J.K.; Lee, J.C.; Beversdorf, D.Q. Docosahexaenoic acid (DHA): An essential nutrient and a nutraceutical for brain health and diseases. Prostaglandins Leukot. Essent. Fat. Acids 2018, 136, 3–13. [Google Scholar] [CrossRef] [PubMed]
- Martinat, M.; Rossitto, M.; Di Miceli, M.; Layé, S. Perinatal Dietary Polyunsaturated Fatty Acids in Brain Development, Role in Neurodevelopmental Disorders. Nutrients 2021, 13, 1185. [Google Scholar] [CrossRef]
- Weiser, M.; Butt, C.; Mohajeri, M. Docosahexaenoic Acid and Cognition throughout the Lifespan. Nutrients 2016, 8, 99. [Google Scholar] [CrossRef]
- Astarita, G.; Jung, K.-M.; Berchtold, N.C.; Nguyen, V.Q.; Gillen, D.L.; Head, E.; Cotman, C.W.; Piomelli, D. Deficient Liver Biosynthesis of Docosahexaenoic Acid Correlates with Cognitive Impairment in Alzheimer’s Disease. PLoS ONE 2010, 5, e12538. [Google Scholar] [CrossRef] [Green Version]
- Bazan, N.G.; Molina, M.F.; Gordon, W.C. Docosahexaenoic Acid Signalolipidomics in Nutrition: Significance in Aging, Neuroinflammation, Macular Degeneration, Alzheimer’s, and Other Neurodegenerative Diseases. Annu. Rev. Nutr. 2011, 31, 321–351. [Google Scholar] [CrossRef] [Green Version]
- Tully, A.M.; Roche, H.M.; Doyle, R.; Fallon, C.; Bruce, I.; Lawlor, B.; Coakley, D.; Gibney, M.J. Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer’s disease: A case-control study. Br. J. Nutr. 2003, 89, 483–489. [Google Scholar] [CrossRef]
- Mett, J. The Impact of Medium Chain and Polyunsaturated ω-3-Fatty Acids on Amyloid-β Deposition, Oxidative Stress and Metabolic Dysfunction Associated with Alzheimer’s Disease. Antioxidants 2021, 10, 1991. [Google Scholar] [CrossRef]
- Hashimoto, M.; Katakura, M.; Hossain, S.; Rahman, A.; Shimada, T.; Shido, O. Docosahexaenoic acid withstands the Aβ(25-35)-induced neurotoxicity in SH-SY5Y cells. J. Nutr. Biochem. 2011, 22, 22–29. [Google Scholar] [CrossRef] [PubMed]
- Swanson, D.; Block, R.; Mousa, S.A. Omega-3 fatty acids EPA and DHA: Health benefits throughout life. Adv. Nutr. 2012, 3, 1–7. [Google Scholar] [CrossRef] [PubMed]
- Zhang, Y.; Chen, J.; Qiu, J.; Li, Y.; Wang, J.; Jiao, J. Intakes of fish and polyunsaturated fatty acids and mild-to-severe cognitive impairment risks: A dose-response meta-analysis of 21 cohort studies. Am. J. Clin. Nutr 2016, 103, 330–340. [Google Scholar] [CrossRef] [PubMed]
- Lauritzen, L.; Brambilla, P.; Mazzocchi, A.; Harsløf, L.; Ciappolino, V.; Agostoni, C. DHA Effects in Brain Development and Function. Nutrients 2016, 8, 6. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Liao, Y.; Xie, B.; Zhang, H.; He, Q.; Guo, L.; Subramanieapillai, M.; Fan, B.; Lu, C.; McIntyre, R.S. Efficacy of omega-3 PUFAs in depression: A meta-analysis. Transl. Psychiatry 2019, 9, 190. [Google Scholar] [CrossRef] [Green Version]
- Avallone, R.; Vitale, G.; Bertolotti, M. Omega-3 Fatty Acids and Neurodegenerative Diseases: New Evidence in Clinical Trials. Int. J. Mol. Sci. 2019, 20, 4256. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015, 385, 117–171. [Google Scholar] [CrossRef]
- Chamani, S.; Bianconi, V.; Tasbandi, A.; Pirro, M.; Barreto, G.E.; Jamialahmadi, T.; Sahebkar, A. Resolution of Inflammation in Neurodegenerative Diseases: The Role of Resolvins. Mediat. Inflamm. 2020, 2020, 3267172. [Google Scholar] [CrossRef]
- Xu, J.; Gao, X.; Yang, C.; Chen, L.; Chen, Z. Resolvin D1 Attenuates Mpp+-Induced Parkinson Disease via Inhibiting Inflammation in PC12 Cells. Med. Sci. Monit. 2017, 23, 2684–2691. [Google Scholar] [CrossRef] [Green Version]
- Ozkan, A.; Parlak, H.; Tanriover, G.; Dilmac, S.; Ulker, S.N.; Birsen, L.; Agar, A. The protective mechanism of docosahexaenoic acid in mouse model of Parkinson: The role of heme oxygenase. Neurochem. Int. 2016, 101, 110–119. [Google Scholar] [CrossRef]
- da Silva, T.M.; Munhoz, R.P.; Alvarez, C.; Naliwaiko, K.; Kiss, Á.; Andreatini, R.; Ferraz, A.C. Depression in Parkinson’s disease: A double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation. J. Affect. Disord. 2008, 111, 351–359. [Google Scholar] [CrossRef] [PubMed]
- de Mello, A.H.; Uberti, M.F.; de Farias, B.X.; de Souza, N.A.R.; Rezin, G.T. n-3 PUFA and obesity: From peripheral tissues to the central nervous system. Br. J. Nutr. 2018, 119, 1312–1323. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Siroma, T.K.; Machate, D.J.; Zorgetto-Pinheiro, V.A.; Figueiredo, P.S.; Marcelino, G.; Hiane, P.A.; Bogo, D.; Pott, A.; Cury, E.R.J.; Guimarães, R.C.A.; et al. Polyphenols and ω-3 PUFAs: Beneficial Outcomes to Obesity and Its Related Metabolic Diseases. Front. Nutr. 2021, 8, 781622. [Google Scholar] [CrossRef] [PubMed]
- Neto, J.; Jantsch, J.; de Oliveira, S.; Braga, M.F.; Castro, L.; Diniz, B.F.; Moreira, J.C.F.; Giovenardi, M.; Porawski, M.; Guedes, R.P. DHA/EPA supplementation decreases anxiety-like behaviour, but it does not ameliorate metabolic profile in obese male rats. Br. J. Nutr. 2021, 1–11. [Google Scholar] [CrossRef] [PubMed]
- Bender, N.; Portmann, M.; Heg, Z.; Hofmann, K.; Zwahlen, M.; Egger, M. Fish or n3-PUFA intake and body composition: A systematic review and meta-analysis. Obes. Rev. 2014, 15, 657–665. [Google Scholar] [CrossRef] [PubMed]
- Du, S.; Jin, J.; Fang, W.; Su, Q. Does Fish Oil Have an Anti-Obesity Effect in Overweight/Obese Adults? A Meta-Analysis of Randomized Controlled Trials. PLoS ONE 2015, 10, e0142652. [Google Scholar] [CrossRef] [PubMed]
- Zhang, Y.Y.; Liu, W.; Zhao, T.Y.; Tian, H.M. Efficacy of Omega-3 Polyunsaturated Fatty Acids Supplementation in Managing Overweight and Obesity: A Meta-Analysis of Randomized Clinical Trials. J. Nutr. Health Aging 2017, 21, 187–192. [Google Scholar] [CrossRef]
- De Souza, C.T.; Araujo, E.P.; Bordin, S.; Ashimine, R.; Zollner, R.L.; Boschero, A.C.; Saad, M.J.; Velloso, L.A. Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology 2005, 146, 4192–4199. [Google Scholar] [CrossRef] [Green Version]
- Milanski, M.; Degasperi, G.; Coope, A.; Morari, J.; Denis, R.; Cintra, D.E.; Tsukumo, D.M.; Anhe, G.; Amaral, M.E.; Takahashi, H.K.; et al. Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: Implications for the pathogenesis of obesity. J. Neurosci. 2009, 29, 359–370. [Google Scholar] [CrossRef]
- Zhang, X.; Zhang, G.; Zhang, H.; Karin, M.; Bai, H.; Cai, D. Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity. Cell 2008, 135, 61–73. [Google Scholar] [CrossRef] [Green Version]
- Moraes, J.C.; Coope, A.; Morari, J.; Cintra, D.E.; Roman, E.A.; Pauli, J.R.; Romanatto, T.; Carvalheira, J.B.; Oliveira, A.L.; Saad, M.J.; et al. High-fat diet induces apoptosis of hypothalamic neurons. PLoS ONE 2009, 4, e5045. [Google Scholar] [CrossRef] [PubMed]
- Cintra, D.E.; Ropelle, E.R.; Moraes, J.C.; Pauli, J.R.; Morari, J.; Souza, C.T.; Grimaldi, R.; Stahl, M.; Carvalheira, J.B.; Saad, M.J.; et al. Unsaturated fatty acids revert diet-induced hypothalamic inflammation in obesity. PLoS ONE 2012, 7, e30571. [Google Scholar] [CrossRef] [PubMed]
- Pimentel, G.D.; Lira, F.S.; Rosa, J.C.; Oller do Nascimento, C.M.; Oyama, L.M.; Harumi Watanabe, R.L.; Ribeiro, E.B. High-fat fish oil diet prevents hypothalamic inflammatory profile in rats. ISRN Inflamm. 2013, 2013, 419823. [Google Scholar] [CrossRef]
- de Mello, A.H.; Schraiber, R.B.; Goldim, M.P.S.; Garcez, M.L.; Gomes, M.L.; de Bem Silveira, G.; Zaccaron, R.P.; Schuck, P.F.; Budni, J.; Silveira, P.C.L.; et al. Omega-3 Fatty Acids Attenuate Brain Alterations in High-Fat Diet-Induced Obesity Model. Mol. Neurobiol. 2019, 56, 513–524. [Google Scholar] [CrossRef] [PubMed]
- Viggiano, E.; Mollica, M.P.; Lionetti, L.; Cavaliere, G.; Trinchese, G.; De Filippo, C.; Chieffi, S.; Gaita, M.; Barletta, A.; De Luca, B.; et al. Effects of an High-Fat Diet Enriched in Lard or in Fish Oil on the Hypothalamic Amp-Activated Protein Kinase and Inflammatory Mediators. Front. Cell. Neurosci. 2016, 10, 150. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cheng, L.; Hu, T.; Shi, H.; Chen, X.; Wang, H.; Zheng, K.; Huang, X.F.; Yu, Y. DHA reduces hypothalamic inflammation and improves central leptin signaling in mice. Life Sci. 2020, 257, 118036. [Google Scholar] [CrossRef]
- Abdel-Maksoud, S.M.; Hassanein, S.I.; Gohar, N.A.; Attia, S.M.M.; Gad, M.Z. Investigation of brain-derived neurotrophic factor (BDNF) gene expression in hypothalamus of obese rats: Modulation by omega-3 fatty acids. Nutr. Neurosci. 2017, 20, 443–448. [Google Scholar] [CrossRef]
- Merendino, N.; Costantini, L.; Manzi, L.; Molinari, R.; D’Eliseo, D.; Velotti, F. Dietaryω-3 Polyunsaturated Fatty Acid DHA: A Potential Adjuvant in the Treatment of Cancer. BioMed Res. Int. 2013, 2013, 310186. [Google Scholar] [CrossRef] [Green Version]
- Jeong, S.; Jing, K.; Kim, N.; Shin, S.; Kim, S.; Song, K.-S.; Heo, J.-Y.; Park, J.-H.; Seo, K.-S.; Han, J.; et al. Docosahexaenoic acid-induced apoptosis is mediated by activation of mitogen-activated protein kinases in human cancer cells. BMC Cancer 2014, 14, 481. [Google Scholar] [CrossRef] [Green Version]
- D’Eliseo, D.; Velotti, F. Omega-3 Fatty Acids and Cancer Cell Cytotoxicity: Implications for Multi-Targeted Cancer Therapy. J. Clin. Med. 2016, 5, 15. [Google Scholar] [CrossRef] [Green Version]
- Rose, D.P.; Connolly, J.M. Effects of fatty acids and inhibitors of eicosanoid synthesis on the growth of a human breast cancer cell line in culture. Cancer Res. 1990, 50, 7139–7144. [Google Scholar] [PubMed]
- Tsai, W.-S.; Nagawa, H.; Kaizaki, S.; Tsuruo, T.; Muto, T. Inhibitory effects of n-3 polyunsaturated fatty acids on sigmoid colon cancer transformants. J. Gastroenterol. 1998, 33, 206–212. [Google Scholar] [CrossRef] [PubMed]
- Lee, S.E.; Lim, J.W.; Kim, H. Activator protein-1 mediates docosahexaenoic acid-induced apoptosis of human gastric cancer cells. Ann. N. Y. Acad. Sci. 2009, 1171, 163–169. [Google Scholar] [CrossRef] [PubMed]
- Albino, A.P.; Juan, G.; Traganos, F.; Reinhart, L.; Connolly, J.; Rose, D.P.; Darzynkiewicz, Z. Cell cycle arrest and apoptosis of melanoma cells by docosahexaenoic acid: Association with decreased pRb phosphorylation. Cancer Res. 2000, 60, 4139–4145. [Google Scholar]
- Sharma, A.; Belna, J.; Logan, J.; Espat, J.; Hurteau, J.A. The effects of Omega-3 fatty acids on growth regulation of epithelial ovarian cancer cell lines. Gynecol. Oncol. 2005, 99, 58–64. [Google Scholar] [CrossRef]
- Lim, K.; Han, C.; Xu, L.; Isse, K.; Demetris, A.J.; Wu, T. Cyclooxygenase-2–Derived Prostaglandin E2 Activates β-Catenin in Human Cholangiocarcinoma Cells: Evidence for Inhibition of These Signaling Pathways by ω3 Polyunsaturated Fatty Acids. Cancer Res. 2008, 68, 553–560. [Google Scholar] [CrossRef] [Green Version]
- Kubota, H.; Matsumoto, H.; Higashida, M.; Murakami, H.; Nakashima, H.; Oka, Y.; Okumura, H.; Yamamura, M.; Nakamura, M.; Hirai, T. Eicosapentaenoic acid modifies cytokine activity and inhibits cell proliferation in an oesophageal cancer cell line. Anticancer Res. 2013, 33, 4319–4324. [Google Scholar]
- Glatz, J.F.C.; Luiken, J.J.F.P.; van Nieuwenhoven, F.A.; Van der Vusse, G.J. Molecular mechanism of cellular uptake and intracellular translocation of fatty acids. Prostaglandins Leukot. Essent. Fat. Acids 1997, 57, 3–9. [Google Scholar] [CrossRef]
- Siddiqui, R.A.; Harvey, K.; Stillwell, W. Anticancer properties of oxidation products of docosahexaenoic acid. Chem. Phys. Lipids 2008, 153, 47–56. [Google Scholar] [CrossRef]
- Siddiqui, R.A.; Harvey, K.A.; Xu, Z.; Bammerlin, E.M.; Walker, C.; Altenburg, J.D. Docosahexaenoic acid: A natural powerful adjuvant that improves efficacy for anticancer treatment with no adverse effects. BioFactors 2011, 37, 399–412. [Google Scholar] [CrossRef]
- Biondo, P.D.; Brindley, D.N.; Sawyer, M.B.; Field, C.J. The potential for treatment with dietary long-chain polyunsaturated n-3 fatty acids during chemotherapy. J. Nutr. Biochem. 2008, 19, 787–796. [Google Scholar] [CrossRef] [PubMed]
- Gleissman, H.; Yang, R.; Martinod, K.; Lindskog, M.; Serhan, C.N.; Johnsen, J.I.; Kogner, P. Docosahexaenoic acid metabolome in neural tumors: Identification of cytotoxic intermediates. FASEB J. 2010, 24, 906–915. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- de Robles, P.; Fiest, K.M.; Frolkis, A.D.; Pringsheim, T.; Atta, C.; Germaine-Smith, C.S.; Day, L.; Lam, D.; Jette, N. The worldwide incidence and prevalence of primary brain tumors: A systematic review and meta-analysis. Neuro-Oncology 2014, 17, 776–783. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Central Brain Tumor Registry of the United States (CBTRUS). CBTRUS Fact Sheet 2021. Available online: https://cbtrus.org/cbtrus-fact-sheet-2021/ (accessed on 22 February 2022).
- Ostrom, Q.T.; Gittleman, H.; Truitt, G.; Boscia, A.; Kruchko, C.; Barnholtz-Sloan, J.S. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015. Neuro-Oncology 2018, 20 (Suppl. S4), iv1–iv86. [Google Scholar] [CrossRef] [Green Version]
- Nayak, L.; Lee, E.Q.; Wen, P.Y. Epidemiology of Brain Metastases. Curr. Oncol. Rep. 2012, 14, 48–54. [Google Scholar] [CrossRef]
- Fecci, P.E.; Champion, C.D.; Hoj, J.; McKernan, C.M.; Goodwin, C.R.; Kirkpatrick, J.P.; Anders, C.K.; Pendergast, A.M.; Sampson, J.H. The Evolving Modern Management of Brain Metastasis. Clin. Cancer Res. 2019, 25, 6570–6580. [Google Scholar] [CrossRef] [Green Version]
- Hachem, M.; Belkouch, M.; Lo Van, A.; Picq, M.; Bernoud-Hubac, N.; Lagarde, M. Brain targeting with docosahexaenoic acid as a prospective therapy for neurodegenerative diseases and its passage across blood brain barrier. Biochimie 2020, 170, 203–211. [Google Scholar] [CrossRef]
- Wang, F.; Bhat, K.; Doucette, M.; Zhou, S.; Gu, Y.; Law, B.; Liu, X.; Wong, E.T.; Kang, J.X.; Hsieh, T.C.; et al. Docosahexaenoic Acid (DHA) Sensitizes Brain Tumor Cells to Etoposide-Induced Apoptosis. Curr. Mol. Med. 2011, 11, 503–511. [Google Scholar] [CrossRef] [Green Version]
- Elsherbiny, M.; Chen, H.; Emara, M.; Godbout, R. ω-3 and ω-6 Fatty Acids Modulate Conventional and Atypical Protein Kinase C Activities in a Brain Fatty Acid Binding Protein Dependent Manner in Glioblastoma Multiforme. Nutrients 2018, 10, 454. [Google Scholar] [CrossRef] [Green Version]
- Harvey, K.A.; Xu, Z.; Saaddatzadeh, M.R.; Wang, H.; Pollok, K.; Cohen-Gadol, A.A.; Siddiqui, R.A. Enhanced anticancer properties of lomustine in conjunction with docosahexaenoic acid in glioblastoma cell lines. J. Neurosurg. 2015, 122, 547–556. [Google Scholar] [CrossRef] [Green Version]
- Vartak, S.; Robbins, M.E.C.; Spector, A.A. Polyunsaturated fatty acids increase the sensitivity of 36B10 rat astrocytoma cells to radiation-induced cell kill. Lipids 1997, 32, 283. [Google Scholar] [CrossRef] [PubMed]
- Moloudizargari, M.; Mortaz, E.; Asghari, M.H.; Adcock, I.M.; Redegeld, F.A.; Garssen, J. Effects of the polyunsaturated fatty acids, EPA and DHA, on hematological malignancies: A systematic review. Oncotarget 2018, 9, 11858–11875. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Newell, M.; Mackey, J.R.; Bigras, G.; Alvarez-Camacho, M.; Goruk, S.; Ghosh, S.; Schmidt, A.; Miede, D.; Chisotti, A.; Postovit, L.; et al. Comparing docosahexaenoic acid (DHA) concomitant with neoadjuvant chemotherapy versus neoadjuvant chemotherapy alone in the treatment of breast cancer (DHA WIN): Protocol of a double-blind, phase II, randomised controlled trial. BMJ Open 2019, 9, e030502. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Murata, M. Inflammation and cancer. Environ. Health Prev. Med. 2018, 23, 50. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hanahan, D. Hallmarks of Cancer: New Dimensions. Cancer Discov. 2022, 12, 31–46. [Google Scholar] [CrossRef]
- Ohnishi, S.; Ma, N.; Thanan, R.; Pinlaor, S.; Hammam, O.; Murata, M.; Kawanishi, S. DNA Damage in Inflammation-Related Carcinogenesis and Cancer Stem Cells. Oxidative Med. Cell. Longev. 2013, 2013, 387014. [Google Scholar] [CrossRef]
- Ghanbari Movahed, Z.; Rastegari-Pouyani, M.; Mohammadi, M.H.; Mansouri, K. Cancer cells change their glucose metabolism to overcome increased ROS: One step from cancer cell to cancer stem cell? Biomed. Pharmacother. 2019, 112, 108690. [Google Scholar] [CrossRef]
- Greten, F.R.; Grivennikov, S.I. Inflammation and Cancer: Triggers, Mechanisms, and Consequences. Immunity 2019, 51, 27–41. [Google Scholar] [CrossRef]
- Miller, A.H.; Ancoli-Israel, S.; Bower, J.E.; Capuron, L.; Irwin, M.R. Neuroendocrine-Immune Mechanisms of Behavioral Comorbidities in Patients with Cancer. J. Clin. Oncol. 2008, 26, 971–982. [Google Scholar] [CrossRef] [Green Version]
- Arita, M. Mediator lipidomics in acute inflammation and resolution. J. Biochem. 2012, 152, 313–319. [Google Scholar] [CrossRef] [Green Version]
- Houthuijzen, J.M. For Better or Worse: FFAR1 and FFAR4 Signaling in Cancer and Diabetes. Mol. Pharmacol. 2016, 90, 738–743. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Freitas, R.; Campos, M.M. Protective Effects of Omega-3 Fatty Acids in Cancer-Related Complications. Nutrients 2019, 11, 945. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Fukushima, K.; Takahashi, K.; Kusaka, M.; Ishimoto, K.; Minami, K.; Otagaki, S.; Fukushima, N.; Honoki, K.; Tsujiuchi, T. Induction of GPR40 positively regulates cell motile and growth activities in breast cancer MCF-7 cells. J. Recept. Signal. Transduct. 2018, 38, 311–315. [Google Scholar] [CrossRef] [PubMed]
- Nakashima, C.; Shingo, K.; Fujiwara-Tani, R.; Luo, Y.; Kawahara, I.; Goto, K.; Sasaki, T.; Fujii, K.; Ohmori, H.; Kuniyasu, H. Expression of long-chain fatty acid receptor GPR40 is associated with cancer progression in colorectal cancer: A retrospective study. Oncol. Lett. 2018, 15, 8641–8646. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lohse, I.; Brothers, S.P. Pathogenesis and Treatment of Pancreatic Cancer Related Pain. Anticancer. Res. 2020, 40, 1789–1796. [Google Scholar] [CrossRef]
- Bamonti, P.M.; Moye, J.; Naik, A.D. Pain is associated with continuing depression in cancer survivors. Psychol. Health Med. 2018, 23, 1182–1195. [Google Scholar] [CrossRef]
- Josephy-Hernandez, S.; Jmaeff, S.; Pirvulescu, I.; Aboulkassim, T.; Saragovi, H.U. Neurotrophin receptor agonists and antagonists as therapeutic agents: An evolving paradigm. Neurobiol. Dis. 2017, 97, 139–155. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Petermann, A.B.; Reyna-Jeldes, M.; Ortega, L.; Coddou, C.; Yévenes, G.E. Roles of the Unsaturated Fatty Acid Docosahexaenoic Acid in the Central Nervous System: Molecular and Cellular Insights. Int. J. Mol. Sci. 2022, 23, 5390. https://doi.org/10.3390/ijms23105390
Petermann AB, Reyna-Jeldes M, Ortega L, Coddou C, Yévenes GE. Roles of the Unsaturated Fatty Acid Docosahexaenoic Acid in the Central Nervous System: Molecular and Cellular Insights. International Journal of Molecular Sciences. 2022; 23(10):5390. https://doi.org/10.3390/ijms23105390
Chicago/Turabian StylePetermann, Ana B., Mauricio Reyna-Jeldes, Lorena Ortega, Claudio Coddou, and Gonzalo E. Yévenes. 2022. "Roles of the Unsaturated Fatty Acid Docosahexaenoic Acid in the Central Nervous System: Molecular and Cellular Insights" International Journal of Molecular Sciences 23, no. 10: 5390. https://doi.org/10.3390/ijms23105390